{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:59:26Z","timestamp":1775080766760,"version":"3.50.1"},"reference-count":18,"publisher":"BMJ","issue":"6646","license":[{"start":{"date-parts":[[1988,8,13]],"date-time":"1988-08-13T00:00:00Z","timestamp":587433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,8,13]]},"abstract":"<jats:p>STUDY OBJECTIVE--To determine whether salbutamol is more effective in treating severe asthma when given intravenously or by inhalation. DESIGN--Randomised trial of short term response to intravenous versus nebulised salbutamol in acute severe asthma. SETTING--District general hospital (secondary care centre). PARTICIPANTS--76 patients aged 16-70 admitted to hospital with acute severe asthma (peak expiratory flow rate less than 50% of predicted) during study period. Five withdrawn because of adverse effects of treatment or non-response. Of remaining 71, 34 allocated to nebuliser group and 37 to intravenous treatment group. Patients with history of cardiovascular disease or recent corticosteroid or intravenous bronchodilator treatment excluded. Admission characteristics similar in the two groups. INTERVENTIONS--All patients given 5 mg nebulised salbutamol on admission before randomisation plus 200 mg hydrocortisone bolus intravenously and 35% inspired oxygen throughout. Nebuliser group received two more 5 mg doses of nebuliser salbutamol at 30 minutes and 2 hours; intravenous group received 4 hours' continuous salbutamol infusion (12 micrograms\/min) starting at 30 minutes plus supplementary intravenous potassium chloride. No other bronchodilators used. ENDPOINT--Change in peak expiratory flow rate over 4 hours. MEASUREMENTS and MAIN RESULTS--Peak expiratory flow rate improved more in intravenous group (25.2%) than in nebuliser group (14.3%) (p less than 0.01, 95% confidence interval 2.4 to 19.1%). Tachycardia caused two withdrawals from intravenous group; non-response caused three withdrawals from nebuliser group. CONCLUSIONS--Intravenous salbutamol is more effective than nebulised salbutamol in acute severe asthma but may have unacceptable cardiovascular effects.<\/jats:p>","DOI":"10.1136\/bmj.297.6646.448","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"448-450","source":"Crossref","is-referenced-by-count":37,"title":["Intravenous beta agonist in severe acute asthma."],"prefix":"10.1136","volume":"297","author":[{"given":"B.","family":"Cheong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1988,8,13]]},"reference":[{"key":"ref_1","first-page":"495","article-title":"Effect of intravenous injection of salbutamol in asthma. BrJ7 Clin Phar, nacol","volume":"2","author":"Spiro, S.G.; Johnson, A.J.; May, C.S.; Paterson, J.W.","year":"1975","unstructured":"Spiro SG, Johnson AJ, May CS, Paterson JW. Effect of intravenous injection of salbutamol in asthma. BrJ7 Clin Phar,nacol 1975;2:495-501."},{"key":"ref_2","first-page":"919","article-title":"Comparison of intravenous and aerosol salbutamol","volume":"ii:","author":"Hetzel, M.R.; Clark, T.J.H.","year":"1976","unstructured":"Hetzel MR, Clark TJH. Comparison of intravenous and aerosol salbutamol. BrMedJ 1976;ii:919.","journal-title":"BrMedJ"},{"key":"ref_3","article-title":"Comparison of intravenous and nebulised salbutamnol in initial treatment of severe asthma","volume":"7","author":"Lawford, P.; Jones, B.J.M.; Milledge, J.S.","year":"1978","unstructured":"Lawford P, Jones BJM, Milledge JS. Comparison of intravenous and nebulised salbutamnol in initial treatment of severe asthma. Br Med 7 1978;i:84.","journal-title":"Br Med"},{"key":"ref_4","first-page":"848","article-title":"Comparison of salbutamol given intravenously and by intermittent positive pressure breathing in life threatening asthma","volume":"i:","author":"Bloomfield, P.; Carmichael, J.; Petrie, G.R.; Jewell, N.P.; Crompton, G.K.","year":"1979","unstructured":"Bloomfield P, Carmichael J, Petrie GR, Jewell NP, Crompton GK. Comparison of salbutamol given intravenously and by intermittent positive pressure breathing in life threatening asthma. BrMedJf 1979;i:848-50.","journal-title":"BrMedJf"},{"key":"ref_5","first-page":"1336","article-title":"Statistics and ethics in medical research. III. How large a sample?","volume":"281","author":"Altman, D.","year":"1980","unstructured":"Altman D. Statistics and ethics in medical research. III. How large a sample? BrMedJ 1980;281:1336-8.","journal-title":"BrMedJ"},{"key":"ref_6","first-page":"259","article-title":"The use of corticosteroids in the treatment of acute severe asthma","volume":"44","author":"Collins, J.V.; Clark, T.J.H.; Brown, D.; Townsend, J.","year":"1975","unstructured":"Collins JV, Clark TJH, Brown D, Townsend J. The use of corticosteroids in the treatment of acute severe asthma. QJf Med 1975;44:259-73.","journal-title":"QJf Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.41.11.824","article-title":"Clinical trials in acute severe asthma: are type two errors important?","volume":"41","author":"Ward, M.J.","year":"1986","unstructured":"Ward MJ. Clinical trials in acute severe asthma: are type two errors important? Thorax 1986;41:824-9.","journal-title":"Thorax"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/thx.32.5.555","article-title":"Intravenous or inhaled salbutamol in severe acute asthma?","volume":"32","author":"Williams, S.; Seaton, A.","year":"1977","unstructured":"Williams S, Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax 1977;32:555-8.","journal-title":"Thorax"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0091-6749(77)90211-1","article-title":"Assessing bronchodilator responsiveness","volume":"59","author":"Tinkelman, D.G.; Avner, S.E.; Cooper, D.M.","year":"1977","unstructured":"Tinkelman DG, Avner SE, Cooper DM. Assessing bronchodilator responsiveness. 7 Allergy Clin Immunol 1977;59:109-14.","journal-title":"7 Allergy Clin Immunol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2125.1975.tb00567.x","article-title":"Intravenous infusion of salbutamol in the treatment of asthma","volume":"2","author":"May, C.S.; Paterson, J.W.; Spiro, S.G.; Johnson, A.J.","year":"1975","unstructured":"May CS, Paterson JW, Spiro SG, Johnson AJ. Intravenous infusion of salbutamol in the treatment of asthma. BrJ Clin Pharmnacol 1975;2:503-8.","journal-title":"BrJ Clin Pharmnacol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1398-9995.1959.tb02814.x","article-title":"Death from bronchial asthma","volume":"14","author":"Williams, D.A.; Leopold, J.G.","year":"1959","unstructured":"Williams DA, Leopold JG. Death from bronchial asthma. Acta Allergica [Copenhagen] 1959;14:83-6.","journal-title":"Acta Allergica [Copenhagen]"},{"key":"ref_12","first-page":"53","article-title":"Intravenous salbutamol in management of status asthmaticus","volume":"i:","author":"Fitchett, D.H.; McNicol, M.W.; Riordan, J.F.","year":"1975","unstructured":"Fitchett DH, McNicol MW, Riordan JF. Intravenous salbutamol in management of status asthmaticus. BrMedJ7 1975;i:53-5."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.5694\/j.1326-5377.1976.tb128275.x","article-title":"A controlled trial of intravenous salbutamol and aminophylline in acute asthma","volume":"2","author":"Tribe, A.E.; Wong, R.M.; Robinson, J.S.","year":"1976","unstructured":"Tribe AE, Wong RM, Robinson JS. A controlled trial of intravenous salbutamol and aminophylline in acute asthma. Medj Aust 1976;2:749-52.","journal-title":"Medj Aust"},{"key":"ref_14","first-page":"261","article-title":"Acute asthmaplasma levels and effects of terbutaline i.v. injection","volume":"67","author":"Joe, J.; Carlsson, L.-G.; Hetta, L.; Karlson, B.; Ljungholm, K.","year":"1985","unstructured":"Joe J, Carlsson L-G, Hetta L, Karlson B, Ljungholm K. Acute asthmaplasma levels and effects of terbutaline i.v. injection. Eur J Respir Dis 1985;67:261-8.","journal-title":"Eur J Respir Dis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000194294","article-title":"Hemodynamic and ventilatory effects of intravenous salbutamol in patients affected by cold","volume":"40","author":"Iodice, F.; Rufolo, L.; Piscione, F.; De, Michele G.","year":"1980","unstructured":"Iodice F, Rufolo L, Piscione F, Michele G De. Hemodynamic and ventilatory effects of intravenous salbutamol in patients affected by cold. Respiration 1980;40:272-7.","journal-title":"Respiration"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.1987.tb03224.x","article-title":"Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebocontrolled dose-response study in healthy volunteers","volume":"24","author":"Schemin, M.; Koulu, M.; Laurikainen, E.; Allonen, H.","year":"1987","unstructured":"Schemin M, Koulu M, Laurikainen E, Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebocontrolled dose-response study in healthy volunteers. BrJ7 Clin Pharmacol 1987;24:645-53.","journal-title":"BrJ7 Clin Pharmacol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/thx.32.5.559","article-title":"Metabolic effects of intravenous salbutamol in the course of acute severe asthma","volume":"32","author":"Nogrady, S.G.; Hartley, J.P.R.; Seaton, A.","year":"1977","unstructured":"Nogrady SG, Hartley JPR, Seaton A. Metabolic effects of intravenous salbutamol in the course of acute severe asthma. Thorax 1977;32:559-62.","journal-title":"Thorax"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/thx.42.7.491","article-title":"Emergency use of nebulised bronchodilator drugs in British hospitals","volume":"42","author":"O'Driscoll, B.R.; Cochrane, G.M.","year":"1987","unstructured":"O'Driscoll BR, Cochrane GM. Emergency use of nebulised bronchodilator drugs in British hospitals. Thorax 1987;42:491-3.","journal-title":"Thorax"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.297.6646.448","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.297.6646.448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:45:38Z","timestamp":1765475138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.297.6646.448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,8,13]]},"references-count":18,"journal-issue":{"issue":"6646","published-online":{"date-parts":[[1988,8,13]]},"published-print":{"date-parts":[[1988,8,13]]}},"alternative-id":["10.1136\/bmj.297.6646.448"],"URL":"https:\/\/doi.org\/10.1136\/bmj.297.6646.448","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,8,13]]}}}